A novel biosimilar matches natalizumab in terms of efficacy, safety, and immunogenicity in patients with relapsing remitting multiple sclerosis, results from a new phase 3 trial show.
New recommendations help clinicians communicate technical information to help patients with multiple sclerosis achieve better understanding and self-care.
COVID-19 on the Brain: Neurological Symptoms Persist in Majority of Long-Haulers scienceblog.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from scienceblog.com Daily Mail and Mail on Sunday newspapers.
Neurological symptoms persist most long-haulers miragenews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from miragenews.com Daily Mail and Mail on Sunday newspapers.
Young and healthy 26-year-old woman suffered brain inflammation called CNS lymphocytic vasculitis after mild COVID-19 infection and underwent a series of corticosteroid-based treatments. After six months, the lesions decreased and no new lesions had formed.